Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Seminars in Nephrology
Volume 24, Issue 5, Pages 395-536 (September 2004)
Search Within This Issue
Uremia Research
Edited by Guido Bellinghieri, Vincenzo Savica, Shaul G. Massry

display abstract citation download email a colleague
Display:

free full text =free full text


Introduction Uremia Research free full text
Guido Bellinghieri, Vincenzo Savica, Shaul G. Massry
page 395
Full Text | Full-Text PDF (40 KB)


Factors for increased morbidity and mortality in uremia: Hyperphosphatemia
Nathan W. Levin, Frank A. Gotch, Martin K. Kuhlmann
pages 396-400
Abstract | Full Text | Full-Text PDF (129 KB)


Mechanisms of vascular calcification in uremia
Cecilia M. Giachelli
pages 401-402
Abstract | Full Text | Full-Text PDF (60 KB)


Arterial calcification in chronic kidney disease
Steven K. Burke
pages 403-407
Abstract | Full Text | Full-Text PDF (86 KB)


C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries
Eiji Ishimura, Senji Okuno, Kayoko Kitatani, Kiyoshi Maekawa, Tsuyoshi Izumotani, Tomoyuki Yamakawa, Shuichi Jono, Tetsuo Shoji, Atsushi Shioi, Masaaki Inaba, Shaul G. Massry, Yoshiki Nishizawa
pages 408-412
Abstract | Full Text | Full-Text PDF (168 KB)


Uremic vasculopathy
Sharon M. Moe
pages 413-416
Abstract | Full Text | Full-Text PDF (84 KB)


Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients
Pietro Pozzoni, Marco Pozzi, Lucia Del Vecchio, Francesco Locatelli
pages 417-422
Abstract | Full Text | Full-Text PDF (119 KB)


Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: Another form of metabolic syndrome
Yoshiki Nishizawa, Tetsuo Shoji, Masanori Emoto, Hideki Koyama, Hideki Tahara, Shinya Fukumoto, Masaaki Inaba, Eiji Ishimura, Takami Miki
pages 423-425
Abstract | Full Text | Full-Text PDF (81 KB)


Hyperhomocysteinemia and cardiovascular disease in uremia: The newest evidence in epidemiology and mechanisms of action
Alessandra F. Perna, Filomena Acanfora, Ersilia Satta, Cinzia Lombardi, Diego Ingrosso, Natale G. De Santo
pages 426-430
Abstract | Full Text | Full-Text PDF (90 KB)


Inflammation: Cause of vascular disease and malnutrition in dialysis patients
George A. Kaysen
pages 431-436
Abstract | Full Text | Full-Text PDF (576 KB)


New cellular and molecular approaches for the treatment of cardiac disease
Laurence Kedes, Robert Kloner, Kimi Kong, Coralie Poizat, Boris Simkhovich, Tatsuya Iso, Yasuo Hamamori
pages 437-440
Abstract | Full Text | Full-Text PDF (80 KB)


Chronic systemic inflammation in uremia: Potential therapeutic approaches
Gianfranco Guarnieri, Gianni Biolo, Michela Zanetti, Rocco Barazzoni
pages 441-445
Abstract | Full Text | Full-Text PDF (123 KB)


Management of calcium and bone abnormalities in hemodialysis patients
Hirotoshi Morii, Tayuki Inoue, Takaaki Nishijima, Takashi Tomokuni, Takatoshi Ishikawa, Kenji Moriya, Nobuaki Kawai, Hiroyuki Araki, Misa Horio, Tsutomu Shigeoka, Koji Tani, Tadashi Yamaguchi, Noboru Kubodera
pages 446-448
Abstract | Full Text | Full-Text PDF (71 KB)


Sagliker syndrome: Uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure
Yahya Sagliker, Mustafa Balal, Piril Sagliker Ozkaynak, Saime Paydas, Cemal Sagliker, Hasan Sabit Sagliker, Necati Kiralp, Siddik Mumin Adam, Ilhan Tuncer, Gulfiliz Gonlusen, Mustafa Esenturk, Erdal Gocmez, Hulya Taskapan, Mehdi Yeksan, Ersin Kobaner, Ozan Ozkaya, Musa Yuksekgonul, Idris Emir, Nurdan Cengiz, Ismet Onder Isik, Omer Bilginer, Turgay Guler, Hasan Yakar, Nedim Sarsmaz, Serkan Dilaver, Balim Akoglu, Mustafa Basgumus, Ercin Chirik
pages 449-455
Abstract | Full Text | Full-Text PDF (419 KB)


Vitamin D analogs: Actions and role in the treatment of secondary hyperparathyroidism
Kevin J. Martin, Esther A. González
pages 456-459
Abstract | Full Text | Full-Text PDF (113 KB)


Calcimimetic agents for the treatment of secondary hyperparathyroidism
William G. Goodman
pages 460-463
Abstract | Full Text | Full-Text PDF (71 KB)


Carnitine system in uremic patients: Molecular and clinical aspects
Vincenzo Savica, Menotti Calvani, Paola Benatti, Domencio Santoro, Paolo Monardo, Gianfranco Peluso, Guido Bellinghieri
pages 464-468
Abstract | Full Text | Full-Text PDF (100 KB)


Oxidative stress in uremia: Nature, mechanisms, and potential consequences
Nosratola D. Vaziri
pages 469-473
Abstract | Full Text | Full-Text PDF (93 KB)


Genomic damage in end-stage renal failure: Potential involvement of advanced glycation end products and carbonyl stress
Helga Stopper, Nicole Schupp, Udo Bahner, Katarina Sebekova, Andre Klassen, August Heidland
pages 474-478
Abstract | Full Text | Full-Text PDF (225 KB)


Disturbances of purine nucleotide metabolism in uremia
Bolesław Rutkowski, Julian Swierczynski, Ewa Slominska, Marek Szolkiewicz, Ryszard T. Smolenski, Maciej Marlewski, Barbara Butto, Przemysław Rutkowski
pages 479-483
Abstract | Full Text | Full-Text PDF (137 KB)


Cellular mechanisms causing loss of muscle mass in kidney disease
William E. Mitch, J. Du
pages 484-487
Abstract | Full Text | Full-Text PDF (81 KB)


Ultrastructural changes of corpora cavernosa in men with erectile dysfunction and chronic renal failure
Guido Bellinghieri, Giuseppe Santoro, Domenico Santoro, Bruno Lo Forti, Vincenzo Savica, Pietro Favazzi, Ludovico Magaudda, Arthur H. Cohen
pages 488-491
Abstract | Full Text | Full-Text PDF (319 KB)


The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment
Bruno Memoli, Giuseppina Romano, Rosamunda D’Arcangelo, Marco Del Prete, Pasquale Esposito, Alfredo Procino, Vincenzo Cuomo, Vincenzo Bisesti, Alfredo Capuano, Vittorio E. Andreucci
pages 492-494
Abstract | Full Text | Full-Text PDF (187 KB)


Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients
Daniela Molino, Natale G. De Santo, Rosa Marotta, Pietro Anastasio, Mahrokh Mosavat, Domenico De Lucia
pages 495-501
Abstract | Full Text | Full-Text PDF (431 KB)


Advanced glycation end-products and peritoneal sclerosis
Sakurako Nakamura, Toshimitsu Niwa
pages 502-505
Abstract | Full Text | Full-Text PDF (167 KB)


Continuum of therapy in progressive renal diseases (from predialysis to transplantation): Analysis of a new organizational model
Giuseppe Piccoli, Giorgina Barbara Piccoli, Elisabetta Mezza, Manuel Burdese, Maura Rosetti, Cesare Guarena, Maria Messina, Alfonso Pacitti, Alessandra Thea, Bernardo Malfi, Giorgio Soragna, Massimo Gai, Giovanni Mangiarotti, Alberto Jeantet, Giuseppe Paolo Segoloni, the Soverign Military Order of Malta Working Group, and the High School Education Working Group
pages 506-524
Abstract | Full Text | Full-Text PDF (292 KB)


Vitamin E-coated dialyzer and antioxidant defense parameters: Three-month study
Miroslav Mydlík, Katarína Derzsiová, Oliver Rácz, Anna Šipulová, Eva Lovásová, Angelika Molčányiová, Jozefína Petrovičová
pages 525-531
Abstract | Full Text | Full-Text PDF (336 KB)


Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease
Adalberto Sessa, Mietta Meroni, Graziana Battini, Marco Righetti, Renzo Mignani, SMIMAF
pages 532-536
Abstract | Full Text | Full-Text PDF (93 KB)

Frontmatter


Masthead free full text
page A2
Full Text | Full-Text PDF (35 KB)


Editorial board free full text
page A3
Full Text | Full-Text PDF (28 KB)


Table of contents free full text
pages A5-A7
Full Text | Full-Text PDF (43 KB)

display abstract citation download email a colleague
Display:
Advertisement